| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Androgen receptor as a therapeutic target
|
Gao, Wenqing
|
|
2010
|
|
13 |
p. 1277-1284
8 p.
|
artikel
|
| 2 |
Cell responses to the mechanochemical microenvironment—Implications for regenerative medicine and drug delivery
|
Rehfeldt, Florian
|
|
2007
|
|
13 |
p. 1329-1339
11 p.
|
artikel
|
| 3 |
Cellular and multicellular form and function
|
Liu, Wendy F.
|
|
2007
|
|
13 |
p. 1319-1328
10 p.
|
artikel
|
| 4 |
Clinical experience with anthracycline antibiotics–HPMA copolymer–human immunoglobulin conjugates
|
Rihova, Blanka
|
|
2009
|
|
13 |
p. 1149-1158
10 p.
|
artikel
|
| 5 |
Combination therapy: Opportunities and challenges for polymer–drug conjugates as anticancer nanomedicines
|
Greco, Francesca
|
|
2009
|
|
13 |
p. 1203-1213
11 p.
|
artikel
|
| 6 |
Design and development of IT-101, a cyclodextrin-containing polymer conjugate of camptothecin
|
Davis, Mark E.
|
|
2009
|
|
13 |
p. 1189-1192
4 p.
|
artikel
|
| 7 |
Design and development of polymer conjugates as anti-angiogenic agents
|
Segal, Ehud
|
|
2009
|
|
13 |
p. 1159-1176
18 p.
|
artikel
|
| 8 |
Development of HPMA copolymer–anticancer conjugates: Clinical experience and lessons learnt
|
Duncan, Ruth
|
|
2009
|
|
13 |
p. 1131-1148
18 p.
|
artikel
|
| 9 |
Development of novel therapeutic strategy by regulating the nuclear hormone receptors
|
Xie, Wen
|
|
2010
|
|
13 |
p. 1217-
1 p.
|
artikel
|
| 10 |
Editorial Board
|
|
|
2009
|
|
13 |
p. ii-
1 p.
|
artikel
|
| 11 |
Editorial Board
|
|
|
2010
|
|
13 |
p. ii-
1 p.
|
artikel
|
| 12 |
Editorial Board
|
|
|
2005
|
|
13 |
p. ii-
1 p.
|
artikel
|
| 13 |
Editorial Board
|
|
|
2007
|
|
13 |
p. ii-
1 p.
|
artikel
|
| 14 |
Editorial Board
|
|
|
2011
|
|
13 |
p. ii-
1 p.
|
artikel
|
| 15 |
Editorial Board
|
|
|
2012
|
|
13 |
p. ii-
1 p.
|
artikel
|
| 16 |
Embryonic stem cell science and the therapeutic interface
|
Pouton, Colin W.
|
|
2005
|
|
13 |
p. 1891-1893
3 p.
|
artikel
|
| 17 |
Embryonic stem cells: Meeting the needs for cell therapy
|
Mitjavila-Garcia, Maria Teresa
|
|
2005
|
|
13 |
p. 1935-1943
9 p.
|
artikel
|
| 18 |
Embryonic stem cells: Understanding their history, cell biology and signalling
|
Friel, Ruairi
|
|
2005
|
|
13 |
p. 1894-1903
10 p.
|
artikel
|
| 19 |
Epigenetics advancing personalized nanomedicine in cancer therapy
|
Liu, Shujun
|
|
2012
|
|
13 |
p. 1532-1543
12 p.
|
artikel
|
| 20 |
ES cell technology: An introduction to genetic manipulation, differentiation and therapeutic cloning
|
Hook, Lilian
|
|
2005
|
|
13 |
p. 1904-1917
14 p.
|
artikel
|
| 21 |
Fibroblast mechanics in 3D collagen matrices
|
Rhee, Sangmyung
|
|
2007
|
|
13 |
p. 1299-1305
7 p.
|
artikel
|
| 22 |
Formulating Biomolecules: Mechanistics Insights in Molecular Interactions
|
Chan, Kim
|
|
2011
|
|
13 |
p. 1051-1052
2 p.
|
artikel
|
| 23 |
Functional crosstalk of CAR–LXR and ROR–LXR in drug metabolism and lipid metabolism
|
Xiao, Lei
|
|
2010
|
|
13 |
p. 1316-1321
6 p.
|
artikel
|
| 24 |
Functional polymers as therapeutic agents: Concept to market place
|
Dhal, Pradeep K.
|
|
2009
|
|
13 |
p. 1121-1130
10 p.
|
artikel
|
| 25 |
Genomic perspectives in inter-individual adverse responses following nanomedicine administration: The way forward
|
Moghimi, S. Moein
|
|
2012
|
|
13 |
p. 1385-1393
9 p.
|
artikel
|
| 26 |
Growth factor binding to the pericellular matrix and its importance in tissue engineering
|
Macri, Lauren
|
|
2007
|
|
13 |
p. 1366-1381
16 p.
|
artikel
|
| 27 |
Hyaluronan-dependent pericellular matrix
|
Evanko, Stephen P.
|
|
2007
|
|
13 |
p. 1351-1365
15 p.
|
artikel
|
| 28 |
Immunomicelles for advancing personalized therapy
|
Sawant, Rupa R.
|
|
2012
|
|
13 |
p. 1436-1446
11 p.
|
artikel
|
| 29 |
Interactions of formulation excipients with proteins in solution and in the dried state
|
Ohtake, Satoshi
|
|
2011
|
|
13 |
p. 1053-1073
21 p.
|
artikel
|
| 30 |
Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine
|
Zhang, Xue-Qing
|
|
2012
|
|
13 |
p. 1363-1384
22 p.
|
artikel
|
| 31 |
Legal and ethical status of stem cells as medicinal products
|
Tsang, Lincoln
|
|
2005
|
|
13 |
p. 1970-1980
11 p.
|
artikel
|
| 32 |
Liposome imaging agents in personalized medicine
|
Petersen, Anncatrine L.
|
|
2012
|
|
13 |
p. 1417-1435
19 p.
|
artikel
|
| 33 |
Microgels and microcapsules in peptide and protein drug delivery
|
Bysell, Helena
|
|
2011
|
|
13 |
p. 1172-1185
14 p.
|
artikel
|
| 34 |
Micromechanical control of cell and tissue development: Implications for tissue engineering
|
Ghosh, Kaustabh
|
|
2007
|
|
13 |
p. 1306-1318
13 p.
|
artikel
|
| 35 |
Molecular fabrications of smart nanobiomaterials and applications in personalized medicine
|
Koutsopoulos, Sotirios
|
|
2012
|
|
13 |
p. 1459-1476
18 p.
|
artikel
|
| 36 |
Molecular level insight into intra-solvent interaction effects on protein stability and aggregation
|
Shukla, Diwakar
|
|
2011
|
|
13 |
p. 1074-1085
12 p.
|
artikel
|
| 37 |
Molecular origins of surfactant-mediated stabilization of protein drugs
|
Lee, Hyo Jin
|
|
2011
|
|
13 |
p. 1160-1171
12 p.
|
artikel
|
| 38 |
Multiple aspects of the interaction of biomacromolecules with inorganic surfaces
|
Fenoglio, Ivana
|
|
2011
|
|
13 |
p. 1186-1209
24 p.
|
artikel
|
| 39 |
Nanoproteomics enabling personalized nanomedicine
|
Nicolini, Claudio
|
|
2012
|
|
13 |
p. 1522-1531
10 p.
|
artikel
|
| 40 |
Nanotheranostics for personalized medicine
|
Mura, Simona
|
|
2012
|
|
13 |
p. 1394-1416
23 p.
|
artikel
|
| 41 |
Natural and artificial cellular microenvironments for soft tissue repair
|
Clark, Richard A.F.
|
|
2007
|
|
13 |
p. 1291-1292
2 p.
|
artikel
|
| 42 |
Nonviral gene transfer as a tool for studying transcription regulation of xenobiotic metabolizing enzymes
|
Bonamassa, Barbara
|
|
2010
|
|
13 |
p. 1250-1256
7 p.
|
artikel
|
| 43 |
Nuclear receptor coregulators as a new paradigm for therapeutic targeting
|
Hsia, Elaine Y.
|
|
2010
|
|
13 |
p. 1227-1237
11 p.
|
artikel
|
| 44 |
Nuclear receptors as drug targets for metabolic disease
|
Schulman, Ira G.
|
|
2010
|
|
13 |
p. 1307-1315
9 p.
|
artikel
|
| 45 |
Nuclear receptors in stem cells and their therapeutic potential
|
Sun, GuoQiang
|
|
2010
|
|
13 |
p. 1299-1306
8 p.
|
artikel
|
| 46 |
Overcoming drug resistance by regulating nuclear receptors
|
Chen, Taosheng
|
|
2010
|
|
13 |
p. 1257-1264
8 p.
|
artikel
|
| 47 |
PEG conjugates in clinical development or use as anticancer agents: An overview
|
Pasut, Gianfranco
|
|
2009
|
|
13 |
p. 1177-1188
12 p.
|
artikel
|
| 48 |
Personalized nanomedicine advancements for stem cell tracking
|
Janowski, Miroslaw
|
|
2012
|
|
13 |
p. 1488-1507
20 p.
|
artikel
|
| 49 |
Personalized nanomedicine: paving the way to the practical clinical utility of genomics and nanotechnology advancements
|
Vizirianakis, Ioannis S.
|
|
2012
|
|
13 |
p. 1359-1362
4 p.
|
artikel
|
| 50 |
Pharmaceutical applications of embryonic stem cells
|
Pouton, Colin W.
|
|
2005
|
|
13 |
p. 1918-1934
17 p.
|
artikel
|
| 51 |
Polymeric carriers: Preclinical safety and the regulatory implications for design and development of polymer therapeutics
|
Gaspar, Rogério
|
|
2009
|
|
13 |
p. 1220-1231
12 p.
|
artikel
|
| 52 |
Polymer therapeutics: Clinical applications and challenges for development
|
Vicent, María J.
|
|
2009
|
|
13 |
p. 1117-1120
4 p.
|
artikel
|
| 53 |
ProLindac™ (AP5346): A review of the development of an HPMA DACH platinum Polymer Therapeutic
|
Nowotnik, David P
|
|
2009
|
|
13 |
p. 1214-1219
6 p.
|
artikel
|
| 54 |
Protein–excipient interactions: Mechanisms and biophysical characterization applied to protein formulation development
|
Kamerzell, Tim J.
|
|
2011
|
|
13 |
p. 1118-1159
42 p.
|
artikel
|
| 55 |
Protein stabilization by cyclodextrins in the liquid and dried state
|
Serno, Tim
|
|
2011
|
|
13 |
p. 1086-1106
21 p.
|
artikel
|
| 56 |
Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR
|
Tolson, Antonia H.
|
|
2010
|
|
13 |
p. 1238-1249
12 p.
|
artikel
|
| 57 |
Reprogrammed cell delivery for personalized medicine
|
Wieland, Markus
|
|
2012
|
|
13 |
p. 1477-1487
11 p.
|
artikel
|
| 58 |
Retinoid pathway and cancer therapeutics
|
Bushue, Nathan
|
|
2010
|
|
13 |
p. 1285-1298
14 p.
|
artikel
|
| 59 |
RNAi-based nanomedicines for targeted personalized therapy
|
Daka, Ala
|
|
2012
|
|
13 |
p. 1508-1521
14 p.
|
artikel
|
| 60 |
Selectively targeting estrogen receptors for cancer treatment
|
Shanle, Erin K.
|
|
2010
|
|
13 |
p. 1265-1276
12 p.
|
artikel
|
| 61 |
Spatiotemporal control over growth factor signaling for therapeutic neovascularization
|
Cao, Lan
|
|
2007
|
|
13 |
p. 1340-1350
11 p.
|
artikel
|
| 62 |
Structural and functional insights into nuclear receptor signaling
|
Jin, Lihua
|
|
2010
|
|
13 |
p. 1218-1226
9 p.
|
artikel
|
| 63 |
The UK Stem Cell Bank: Its role as a public research resource centre providing access to well-characterised seed stocks of human stem cell lines
|
Healy, Lyn
|
|
2005
|
|
13 |
p. 1981-1988
8 p.
|
artikel
|
| 64 |
Three-dimensional microenvironments modulate fibroblast signaling responses
|
Green, J. Angelo
|
|
2007
|
|
13 |
p. 1293-1298
6 p.
|
artikel
|
| 65 |
Transplanting stem cells: Potential targets for immune attack. Modulating the immune response against embryonic stem cell transplantation
|
Boyd, Ashleigh S.
|
|
2005
|
|
13 |
p. 1944-1969
26 p.
|
artikel
|
| 66 |
Tumor-targeting multi-functional nanoparticles for theragnosis: New paradigm for cancer therapy
|
Ryu, Ju Hee
|
|
2012
|
|
13 |
p. 1447-1458
12 p.
|
artikel
|
| 67 |
Using drug-excipient interactions for siRNA delivery
|
Bruno, Katharina
|
|
2011
|
|
13 |
p. 1210-1226
17 p.
|
artikel
|
| 68 |
Viscosity of concentrated therapeutic protein compositions
|
Jezek, Jan
|
|
2011
|
|
13 |
p. 1107-1117
11 p.
|
artikel
|
| 69 |
XMT-1001, a novel polymeric camptothecin pro-drug in clinical development for patients with advanced cancer
|
Yurkovetskiy, Alexander V.
|
|
2009
|
|
13 |
p. 1193-1202
10 p.
|
artikel
|
Tijdschrift beschrijving